GlassScriptPhysician profile
Charles E Kollmer
NPI 1821102047
$13,635.73
in general payments reported to CMS, 2019-2025
8 companies · $1,819 in 2025
The $1,819 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,767 · 2020: $145 · 2021: $5,408 · 2022: $752 · 2023: $823 · 2024: $922 · 2025: $1,819.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,177 · Travel and Lodging: $386.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,177.35 |
| Travel and Lodging | $385.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $5,689.05 | 2019-2021 | |
| Stryker Corporation | $4,471.85 | 2019-2025 | Gamma, Simpliciti, T2 |
| Reel Surgical, INC. | $1,841.52 | 2019-2021 | |
| Zimmer Biomet Holdings, INC. | $1,436.84 | 2019-2025 | Persona |
| Smith+Nephew, INC. | $69.76 | 2023-2025 | Bone Anchors With Arthroscopic Delivery System, Bioinductive Implant With Arthroscopic Delivery System - Medium, Grafix Pl |
| Trice Medical, INC. | $69.70 | 2019-2023 | |
| Vgi Medical, LLC | $45.01 | 2019 | |
| Stimwave Technologies Incorporated | $12.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Charles Kollmer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.